Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Compose a Response to This Article
Other responses
No responses have been published for this article.
